Physician profile
Greg A Howes
NPI 1801074661
$4,568.46
in general payments reported to CMS, 2019-2025
13 companies · $348 in 2025
The $348 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $413 · 2020: $989 · 2021: $995 · 2022: $960 · 2023: $778 · 2024: $85.87 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Entertainment: $51.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.04 |
| Entertainment | $51.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,457.57 | 2021-2023 | Osteocool Rf Ablation System, Vanta Adaptivestim |
| Medtronic USA, INC. | $1,074.65 | 2019-2020 | |
| Depuy Synthes Sales INC. | $632.66 | 2019-2025 | Trumatch, Viper, Teligen |
| Si-Bone, INC. | $295.75 | 2020-2023 | |
| Medical Device Business Services, INC. | $263.93 | 2019 | |
| Stryker Corporation | $240.43 | 2022 | |
| Kuros Biosciences USA, INC | $212.09 | 2025 | Magnetos |
| Boston Scientific Corporation | $95.52 | 2021-2022 | |
| Globus Medical, INC. | $95.02 | 2022 | |
| Arteriocyte Medical Systems, INC. | $67.55 | 2023 | Magellan |
| Ossdsign USA Incorporated | $67.54 | 2023 | |
| Biocomposites INC | $65.75 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Howes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.